Mucinex d and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucinex d (guaifenesin; pseudoephedrine hydrochloride) and Naproxen (naproxen). Common drug interactions include vomiting among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Mucinex d and Naproxen. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Mucinex d?

Mucinex d has active ingredients of guaifenesin; pseudoephedrine hydrochloride. It is often used in sinus congestion. eHealthMe is studying from 1,926 Mucinex d users. Check the latest studies of Mucinex d.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,032 Naproxen users. Check the latest studies of Naproxen.



On Jul, 09, 2026

25 people who take Mucinex d and Naproxen together, and have interactions are studied.

Mucinex d and Naproxen drug interactions.

What are the common drug interactions of Mucinex D and Naproxen, by gender? *:

female:

  1. Vomiting
  2. Abdominal pain upper
  3. Alopecia (absence of hair from areas of the body)
  4. Respiratory tract congestion (blockage on respiratory system)
  5. Therapeutic response unexpected
  6. Arthropathy
  7. Back disorder
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Migraine (headache)
  10. Fatigue (feeling of tiredness)

male:

  1. Constipation
  2. Dizziness
  3. Chronic kidney disease
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Emotional distress
  7. Headache (pain in head)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  10. Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Mucinex D and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Respiratory tract congestion (blockage on respiratory system)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

n/a

30-39:

  1. Tendonitis (a condition that causes pain and swelling of tendons)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Tricuspid valve incompetence (inefficient heart valve)
  4. Urticaria chronic (long lasting rash of round, red welts on the skin that itch intensely)
  5. Vertigo
  6. Weight decreased
  7. Abdominal discomfort
  8. Abnormal behaviour
  9. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  10. Alanine aminotransferase increased

40-49:

  1. Depression
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Headache (pain in head)
  6. Insomnia (sleeplessness)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  9. Neuralgia (pain in one or more nerves)
  10. Pain in extremity

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Depression
  5. Drug ineffective
  6. Emotional distress
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Injection site bruising
  9. Injection site discolouration
  10. Injection site erythema (redness at injection site)

60+:

  1. Body height decreased
  2. Memory impairment
  3. Periportal oedema (swelling from excessive accumulation of watery fluid in periportal)
  4. Therapeutic response unexpected
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Viral infection
  7. Vomiting
  8. Spinal pain (pain in spine)
  9. Spondylitis (an inflammation of the vertebra with spinal cord involvement)
  10. Visual acuity reduced (reduced clearness of vision)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 56.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 44.00%
  3. Hypersensitivity: 5 people, 20.00%
  4. Diabetes: 4 people, 16.00%
  5. Drowsiness: 3 people, 12.00%
  6. Blood Pressure Abnormal: 3 people, 12.00%
  7. Breast Cancer Female: 3 people, 12.00%
  8. Asthma: 3 people, 12.00%
  9. Insomnia (sleeplessness): 3 people, 12.00%
  10. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mucinex d and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mucinex d and Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mucinex d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mucinex d and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin; pseudoephedrine hydrochloride and naproxen (the active ingredients of Mucinex d and Naproxen, respectively), and Mucinex d and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: